Lupus algorithm, pediatric psoriasis guidelines lead dermatology news
Clinical specialty setting and geographic region can affect the diagnosis timing of psoriatic arthritis, disease management and disease burden, according to researchers in a Healio Dermatology story comparing diagnoses within dermatology and rheumatology.
In another popular story, experts discuss new guidelines on pediatric psoriasis from the American Academy of Dermatology and the National Psoriasis Foundation.
Continue reading for last week’s biggest news in dermatology.
PsA diagnosis often delayed in dermatology vs. rheumatology
In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology, according to LOOP, a multicenter study across 44 sites in the U.S. Read more.
Experts publish ‘ comprehensive ’ pediatric psoriasis guidelines
Determining the pediatric guidelines was difficult because many treatments are not approved for use in children, according to co-chair of the committee Alan Menter, MD, chairman of the division of dermatology at Baylor University Medical Center in Dallas. Read more.
Experts create algorithm for management of cutaneous manifestations in lupus
In moderate to severe disease, data on thalidomide showed a moderate benefit; however, it also showed a significant risk for adverse events. Researchers found limited evidence to support methotrexate, mycophenolate mofetil and azathioprine. Cyclophosphamide is beneficial but comes with a high risk for toxicity. Read more.
Opioid workgroup guidelines address treatment of dermatologic postop pain
The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge. Read more.
Consensus-based protocol for vitiligo photography may improve outcomes
Vitiligo experts compiled a protocol for vitiligo photography to improve outcome assessment, foster collaboration and promote communication with patients regarding treatment outcomes, according to findings published in Journal of the American Academy of Dermatology. Read more.